Insulin aspart, recombinant Subcutaneous and Prevymis Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Prevymis Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Prevymis
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Prexxartan
- Insulin aspart, recombinant Subcutaneous-Prexxartan Oral Solution
- Insulin aspart, recombinant Subcutaneous-Prezcobix
- Insulin aspart, recombinant Subcutaneous-Prezista
- Insulin aspart, recombinant Subcutaneous-Prezista (Darunavir Oral Suspension)
- Insulin aspart, recombinant Subcutaneous-Prezista (Darunavir Tablets)
- Prevymis Intravenous-Insulin degludec
- Prevymis Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Prevymis Intravenous-Insulin Degludec (U-100) Vials
- Prevymis Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Prevymis Intravenous-Insulin degludec and liraglutide
- Prevymis Intravenous-Insulin degludec and liraglutide Subcutaneous